Petricciani J C
Genetics Institute, Cambridge, MA 02140.
Vaccine. 1993;11(8):873-7. doi: 10.1016/0264-410x(93)90364-4.
Many knowledgeable people believe that the only real hope for halting the AIDS pandemic rests with safe and effective HIV vaccines that are delivered through a global immunization programme. When such vaccines become a reality, the size of potential target populations for HIV vaccines may well be over 100 million. The costs associated with such a large vaccination programme probably reach the multi-billion dollar level. An international consideration of financing strategies should begin in the near future in order to avoid a repetition of the lag between vaccine availability and widespread use that accompanied the introduction of hepatitis B vaccine.
许多有识之士认为，阻止艾滋病大流行的唯一真正希望在于通过全球免疫计划提供安全有效的艾滋病毒疫苗。当此类疫苗成为现实时，艾滋病毒疫苗潜在目标人群的规模很可能超过1亿。如此大规模疫苗接种计划的成本可能达到数十亿美元级别。为避免出现乙肝疫苗推出时疫苗供应与广泛使用之间的滞后情况，应在不久的将来对融资策略进行国际层面的考量。
